中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
17期
112-112,114
,共2页
呼吸道感染%病原性细菌%检验%耐药性
呼吸道感染%病原性細菌%檢驗%耐藥性
호흡도감염%병원성세균%검험%내약성
Respiratory tract infection%Pathogenic bacteria%Test%Drug resistance
目的：分析呼吸道感染患者病原性细菌的分类及耐药性。方法：2012年8月-2013年12月收治呼吸道感染患者80例，将痰液标本进行分离、培养、鉴定，细菌采用K-B纸片法测定药敏性，真菌采用真菌药敏条进行鉴定。结果：本组80例患者共分离出菌株112株，其中革兰阳性菌58株(51.79%)，革兰阴性菌47株(41.96%)，真菌7株(6.25%)，最常见的感染菌为金黄色葡萄球菌、铜绿假单胞菌及肺炎链球菌。革兰阳性菌主要对青霉素耐药，革兰阴性菌主要对氨苄西林、头孢曲松耐药。结论：呼吸道感染菌主要为革兰阳性菌，多重耐药现象普遍，临床上应加强抗菌药物管理、合理用药，以缓解目前临床上多重耐药性的危机。
目的：分析呼吸道感染患者病原性細菌的分類及耐藥性。方法：2012年8月-2013年12月收治呼吸道感染患者80例，將痰液標本進行分離、培養、鑒定，細菌採用K-B紙片法測定藥敏性，真菌採用真菌藥敏條進行鑒定。結果：本組80例患者共分離齣菌株112株，其中革蘭暘性菌58株(51.79%)，革蘭陰性菌47株(41.96%)，真菌7株(6.25%)，最常見的感染菌為金黃色葡萄毬菌、銅綠假單胞菌及肺炎鏈毬菌。革蘭暘性菌主要對青黴素耐藥，革蘭陰性菌主要對氨芐西林、頭孢麯鬆耐藥。結論：呼吸道感染菌主要為革蘭暘性菌，多重耐藥現象普遍，臨床上應加彊抗菌藥物管理、閤理用藥，以緩解目前臨床上多重耐藥性的危機。
목적：분석호흡도감염환자병원성세균적분류급내약성。방법：2012년8월-2013년12월수치호흡도감염환자80례，장담액표본진행분리、배양、감정，세균채용K-B지편법측정약민성，진균채용진균약민조진행감정。결과：본조80례환자공분리출균주112주，기중혁란양성균58주(51.79%)，혁란음성균47주(41.96%)，진균7주(6.25%)，최상견적감염균위금황색포도구균、동록가단포균급폐염련구균。혁란양성균주요대청매소내약，혁란음성균주요대안변서림、두포곡송내약。결론：호흡도감염균주요위혁란양성균，다중내약현상보편，림상상응가강항균약물관리、합리용약，이완해목전림상상다중내약성적위궤。
Objective:To analyze the classification and drug resistance of pathogenic bacteria in respiratory tract infection patients.Methods:We separated,cultivated,appraised the sputum specimen of 80 cases with respiratory tract infection from August 2012 to December 2013 who were selected.The drug sensitivity was tested by K-B method in bacterial,and fungi were identified with fungal susceptibility.Results:112 pathogens were isolated in 80 cases,including 58 gram positive strains(51.79%),47 strains gram negative bacteria(41.96% ),7 strains fungi(6.25% ).The most common infection bacteria were staphylococcus aureus, pseudomonas aeruginosa and streptococcus pneumoniae.The gram positive bacteria was resistant to penicillin,and the gram negative bacteria was resistant to ampicillin and ceftriaxone.Conclusion:The major respiratory tract infection bacteria was gram positive bacteria,and the multi-drug resistance is widespread.We should strengthen the management of antimicrobial agents and the rational use of drugs,in order to alleviate the current crisis clinical multidrug resistance in Clinical.
